How does MK3's PB Ratio compare to its peers?

Insufficient data to calculate MK3's Price-To-Book Ratio vs. peers for valuation analysis.

How does MK3's PB Ratio compare vs other companies in the DE Healthcare Industry?

Insufficient data to calculate MK3's Price-To-Book Ratio vs. industry for valuation analysis.

What is MK3's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MK3's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of MK3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MK3's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Hande Health DUSE:MK3 Stock Report

Last Price

€2.50

Market Cap

€1.0m

7D

0%

1Y

0%

Updated

19 Feb, 2024

Data

Company Financials

Axenio AG

DUSE:MK3 Stock Report

Market Cap: €1.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MK3 Stock Overview

Provides management consulting services. More details

MK3 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (€1,000K)

My Notes

Capture your thoughts, links and company narrative

Axenio AG Competitors

Learning 2 Sleep L2S

DB:HT6

€85.9k

VITA 34

XTRA:V3V

€71.8m

MedNation

DB:EIF

€4.6m

AS Latvijas Juras medicinas centrs

MUN:UOM

€5.3m

Price History & Performance

Summary of share price highs, lows and changes for Hande Health
Historical stock prices
Current Share Price	€2.50
52 Week High	€2.50
52 Week Low	€2.50
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	0%
5 Year Change	n/a
Change since IPO	56.25%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	MK3	DE Healthcare	DE Market
7D	0%	-3.5%	-2.6%
1Y	0%	15.6%	6.9%

Return vs Industry: MK3 exceeded the German Healthcare industry which returned -1.1% over the past year.

Return vs Market: MK3 exceeded the German Market which returned -1.2% over the past year.

Price Volatility

Is MK3's price volatile compared to industry and market?
MK3 volatility
MK3 Average Weekly Movement	0%
Healthcare Industry Average Movement	4.7%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: MK3 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MK3's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	www.axenio.com

Hande Health AG provides corporate consulting services for the healthcare sector. It focuses on corporate structure consulting and corporate research; the acquisition, sale, rental, and management of real estate; and the acquisition, management, and sale of assets. Hande Health AG was formerly known as Mandarin Capital AG.

Axenio AG Fundamentals Summary

How do Hande Health's earnings and revenue compare to its market cap?
MK3 fundamental statistics
Market cap	€1.00m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is MK3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MK3 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MK3 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/02/19 11:33
End of Day Share Price	2024/02/19 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Axenio AG is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution